Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2019;143(5):1742-1751.e7. Felarca AB, Lowell FC. The total eosinophil count in a nonatopic population. J Allergy. 1967;40(1):16-20. ...
Nucala is not a rescue medicine for asthma attacks.Use only a fast-acting bronchodilator such as albuterol for an asthma attack. Seek medical attention if your breathing problems get worse quickly, or if you think your asthma medications are not working as well. ...
【美泊利单抗Nucala(Mepolizumab)适应症】 (1)适用于表现型为嗜伊红性白血球的严重气喘且控制不良(severe refractory eosinophilic asthma)之成人患者之附加维持治疗。 (2)使用限制: 美泊利单抗Nucala不可使用于治疗其他嗜伊红性白血病疾病。 美泊利单抗Nucala不可使用于缓解急性支气管痉挛或气喘重积状态(status asthmaticus)...
Hear from a peer NUCALA efficacy & safety in SEA | 15:58 An expert in pulmonology and critical care medicine describes how NUCALA can help patients with severe eosinophilic asthma (SEA), including an overview of safety and efficacy data....
Nucala will not treat an asthma attack or exacerbations of asthma (acute bronchospasm or status asthmaticus). Serious hypersensitivity reactions (such as angioedema and urticaria) have been reported in people administered Nucala, usually within hours of administration but sometimes days later. A health ...
which include high-dose inhaled corticosteroids plus at least one additional asthma control medicine, and may include oral corticosteroids. Patients who were shown to benefit from treatment with mepolizumab in the Phase III clinical trials were those with blood eosinophil levels of 150 cells/mcL or ...
NUCALA is a prescription medicine for the treatment of people 12 years of age and older with hypereosinophilic syndrome (HES). When you have HES, your eosinophil [ee-uh-sin-uh-fil] levels are elevated. Elevated levels of eosinophils can lead to inflammation throughout your body. This inflamma...
NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severeasthmaand with an eosinophilic phenotype [seeUse In Specific Populations,Clinical Studies]. Limitations Of Use NUCALA is not indicated for the relief of acute bronchospasm or ...
(1)适用于表现型为嗜伊红性白血球的严重气喘且控制不良(severe refractory eosinophilic asthma)之成人患者之附加维持治疗。 (2)使用限制: 美泊利单抗Nucala不可使用于治疗其他嗜伊红性白血病疾病。 美泊利单抗Nucala不可使用于缓解急性支气管痉挛或气喘重积状态(status asthmaticus)。